Company Interview / Two stocks with "potential"

Chris Scarpato from Alvia Asset Partners discusses the Australian market's landscape, noting it's pricey amidst low expectations for earnings potential. He highlights CSL (ASX:CSL) a large cap with concerns over patents and tariffs, yet sees long-term growth in plasma and immunodeficiency businesses.

Chris also focuses on Domino's (ASX:DMP) noting its varied performance globally. While the Australian sector thrives, areas like France, Germany, and Japan face challenges. With a new CEO and cost focus, franchise profitability is expected to boost growth.

He comments on banks being overpriced compared to a global scale, favouring resilience in old-world businesses. Chris advises caution towards high-growth tech stocks with lofty valuations, suggesting they may struggle to deliver solid returns.